For immediate release: Wednesday, May 26, 2010
Contact: Oversight and Government Reform Press Office, (202) 225-5051

Oversight Committee to Examine Recall of Popular Pediatric Medicines

WASHINGTON – On Thursday, May 26, 2010, the House Committee on Oversight and Government Reform will hold a hearing entitled, “Johnson and Johnson’s Recall of Children’s Tylenol and Other Children’s Medicines.” The hearing will examine the circumstances surrounding the voluntary recall of popular infant and children’s medicines produced by Johnson & Johnson/McNeil Consumer Healthcare.

On May 5, 2010, Chairman Towns and Ranking Member Darrell Issa (R-CA) opened the committee’s investigation into the circumstances surrounding the voluntary recall of widely used pediatric medications. Johnson & Johnson recalled 6 million bottles from over 40 different types of medicines including brands such as Children’s Tylenol, Infants’ Tylenol, Children’s Motrin, and Children’s Benadryl.

The hearing will take place at 10:00 a.m. in room 2154 Rayburn House Office Building.  The witnesses scheduled to testify include:

Panel I

Dr. Joshua M. Sharfstein 
Principal Deputy Commissioner 
U.S. Food & Drug Administration

Accompanied by:

Ms. Deborah M. Autor
Director of the Office of Compliance
Center for Drug Evaluation and Research
Food and Drug Administration; and

Mr. Michael A. Chappell
Acting Associate Commissioner for Regulatory Affairs
Food and Drug Administration

Panel II

Ms. Colleen Goggins
Worldwide Chairman 
Johnson & Johnson Consumer Group

###